Login/Create Account
The journal Phytotherapy Research reported that the plant compound “Sapanon A,” extracted from the wood of Caesalpinia sappan, holds promising potential in treating neurodermatitis (atopic dermatitis), a chronic skin disorder that affects many children.
Research teams from the Chinese Academy of Medical Sciences and the Peking Union Medical College conducted a study. Laboratory experiments on animal models showed that “Sapanon A” significantly improved skin health and reduced inflammation by lowering the production of inflammatory cytokines in skin cells – the main drivers of itching and redness in eczema.
The treated animals displayed marked improvements in skin symptoms, including reduced swelling, redness, and dryness.
Researchers noted that this compound could represent a promising alternative to conventional treatments such as steroids or calcineurin inhibitors, which may carry long-term risks.
They emphasized, however, that current findings are based only on animal models and laboratory tests. Large-scale clinical trials in humans are needed to assess the efficacy and safety of “Sapanon A” before any therapeutic or commercial recommendations can be made.
This discovery marks an important step toward developing plant-based, sustainable therapies for neurodermatitis.
Sources - Agencies
